Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Applied BioSystems To Test Avian Flu Detection Systems Worldwide

This article was originally published in The Pink Sheet Daily

Executive Summary

With trials currently underway in Hong Kong, firm prepares to ship the test around the globe. Applied BioSystems says it could pursue a diagnostic for clinical use with Celera Genomics, but that its aspirations are currently set on offering a tool for global surveillance.

You may also be interested in...



Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts

Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.

National Advertising Division Shuts Down Skincarebrandsreviews Website

NourishMax agreed to discontinue “top pick” claims for its Diamond Infused Eye Cream and fold up its website that looked suspiciously to NAD like advertising in the guise of independent, honest reviews.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS061266

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel